BioSpace News Archive

There is currently no cure for amyotrophic lateral sclerosis (ALS). But new research could open up avenues for better diagnosis and more effective treatment.

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for the Medtronic Fully Implantable Left Ventricular Assist Device (LVAD) for patients with advanced heart failure, currently in development.

NeoDynamics today received confirmation from Intertek (Notified Body) that the improved version of the new system for breast cancer biopsy, NeoNavia, is accepted as an update to the already EU approved study version.

Blink Health, the digital health company on a mission to make prescription drugs affordable for everyone, has appointed Kathy Reardon as Chief Healthcare Counsel. Reardon joins the company with two decades of experience navigating the legal intricacies of the complex and opaque pharmaceutical supply chain.

Deciphera Pharmaceuticals, Inc. (Nasdaq:DCPH), a clinical-stage biopharmaceutical company addressing key mechanisms of tumor drug resistance, today announced the presentation of updated results from its ongoing Phase 1 study of ripretinib, a broad-spectrum KIT and PDGFRα inhibitor, in patients with second-line through fourth-line plus GIST, as well as its Phase 1 study of DCC-3014, an oral inhibitor of CSF1R, in patients with advanced solid tumors.

Health Care Service Corporation (HCSC) announced today a multi-state education and outreach campaign aimed at decreasing the number of uninsured and underinsured Americans.

MXR The Imaging Solution Company (formerly Merry X-Ray Corporation) will be exhibiting for the first time at the Radiological Society of North America (RSNA) Annual Meeting, December 1–6, 2019, at McCormick Place in Chicago, IL.

A new research study recently published as an “In Press” article in the Journal of Antivirals & Antiretrovirals [Volume 11, Issue 3, 2019] concludes that “phytomedical compounds, such as the cardenolide oleandrin, may one day represent a cost-effective therapeutic strategy to help combat enveloped virus infections in developing countries with limited access to modern antivirals.”

Racial and ethnic disparities contribute to pregnancy-related loss of life in Chicago and across the United States

Dr. Sanjay Basu and Dr. Rajiv Narayanaswamy, in conjunction with Stanford Medical School, recently released an article in an August issue of Medical Care that addresses social determinant health factors in the formation of uncontrolled type 2 diabetes mellitus The research is based on terabytes of area level data and claims data on over 1 million patients with Type 2 Diabetes Mellitus.